Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, 10700, Thailand
NCT Number: NCT01989416
The purpose of this study is to determine 2% chlorhexidine wipes are effective in preventing of colonization of multi-drug resistant bacteria in intensive care unit patients.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Interventional
Phase 3
Bangkok, 10700, Thailand
The purpose of this study is to evaluate the usefulness of bathing with chlorhexidine wipe to reduce the risks of multidrug resistant bacteria acquisition and hospital-acquired bloodstream infection among ICU patients
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ICU patients will be bathing with 2% chlorhexidine wipe
Other names: chlorhexidine wipe
The ICU patients will be bathing with Soap
Other names: Control soap
Time frame: 7 days after recieved 2% chlorhexidine wipes
7 days after received 2% chlorhexidine wipes,the microbiology laboratory will process surveillance specimens using either standard culture-based at both nostrils, axillar, groins, rectum
Time frame: 48 hours after recieved 2% chlorhexidine wipes
Mahidol University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07172932
Antibiotic Resistant Infection, Bacterial Infections
Çankaya, Ankara, Turkey (Türkiye)
View Trial DetailsNCT03452839
Antibiotic Resistant Infection, Critical Illness
Dubrava, Croatia
View Trial DetailsNCT03865706
Antibiotic Resistant Infection, Critical Illness
New York, United States
View Trial DetailsNCT05950984
Adult Children, Antibiotic Resistant Infection
London, United Kingdom
View Trial Details